Newly released episode of AI Amplified. Host Dr. Heather Bassett talks to Oren Nissim, CEO and co-founder of Brook Health, a healthcare technology company focused on AI-driven remote care for chronic diseases.
Read More
By Kishore Pendyala – Compliance by design has emerged as a defining advantage for AI‑driven healthcare IT startups, reshaping how they earn trust and compete in a rapidly shifting regulatory landscape. As CMS and ONC continue to refine expectations around data privacy, interoperability, algorithmic transparency, and patient rights, startups that embed…
By Stephanie Fraser – AI is expanding rapidly across healthcare, but its long-term impact will depend on how organizations address deeper structural challenges such as workforce shortages and funding constraints, HIMSS President and CEO Hal Wolf said during the annual HIMSS conference in Las Vegas last week.
By Dr. Nick van Terheyden – Years ago, I was driving across states with a good friend and colleague from Spain. We stopped in at a gas station that had a Subway restaurant on the side. When my Spanish colleague was asked if he wanted his sandwich “To Go,” he looked at me quizzically and asked what they meant (he spoke excellent English).
By Thomas Kluz – The discovery of Yamanaka factors by Nobel laureate Shinya Yamanaka, which can reprogram adult cells into induced pluripotent stem cells, ignited serious scientific interest in whether aging might be partially reversible.
By Ben Hilmes – ViVE has become one of those industry gatherings where real conversations happen. Leaders from across healthcare come together to showcase ideas and pressure-test them. I attended this year with a clear intention: to be present where systems-level change is discussed, and to engage in those conversations in a realistic, accountable way.
By David Pessis – After years with two influential technology organizations, working at the intersection of large-scale systems, product strategy, and engineering execution, I learned that AI innovation moves fastest and delivers the most value when product and engineering operate as a single, unified organization.
By Ben Crocker MD – The debate over the return on investment (ROI) of ambient AI clinical documentation has reached a critical juncture. What began as a narrow question – Do AI scribes increase productivity enough to justify their cost? – has turned into something more revealing: a broader reckoning with how health systems define value in the clinical AI era.
Newly released episode of AI Amplified. Host Dr. Heather Bassett talks to Dr. Erin Palm, Medical Lead at Infinitus Systems Inc., trauma surgeon, and clinical assistant professor of surgery at Stanford University School of Medicine.